CNM-Au8 in Amyotrophic Lateral Sclerosis: The HEALEY ALS Platform Trial.

Writing Committee for the HEALEY ALS Platform Trial, Berry JD, Maragakis NJ, Macklin EA, Chibnik LB, Quintana M, Saville BR, Detry MA, Vestrucci M, Marion J, McGlothlin A, Stommel EW, Chase M, Pothier L, Harkey BA, Yu H, Sherman A, Shefner J, Hall M, Kittle G, Babu S, Andrews J, D'Agostino D, Tustison E, Scirocco E, Giacomelli E, Alameda G, Locatelli E, Ho D, Quick A, Ajroud-Driss S, Katz J, Heitzman D, Appel SH, Shroff S, Felice KJ, Simmons Z, Miller T, Olney N, Weiss MD, Goutman SA, Fernandes JA Jr, Jawdat O, Owegi MA, Foster L, Vu T, Ilieva H, Newman DS, Arcila-Londono X, Jackson C, Ladha S, Heiman-Patterson T, Caress J, Swenson A, Peltier A, Lewis R, Fee D, Elliott M, Bedlack R, Kasarskis EJ, Elman L, Rosenfeld J, Walk D, McIlduff CE, Twydell P, Young E, Johnson K, Rezania K, Goyal NA, Cohen JA, Benatar M, Jones V, Glass J, Shah J, Beydoun SR, Wymer JP, Zilliox L, Nayar S, Pattee GL, Martinez-Thompson J, Rynders A, Evan J, Evan J, Hartford A, Sepassi M, Ho KS, Glanzman R, Greenberg B, Hotchkin MT, Paganoni S, Cudkowicz ME, HEALEY ALS Platform Trial Study Group

Open source

DOI
10.1001/jama.2024.27643
Published
2025 Feb 17
Container
JAMA
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1001/jama.2024.27643,
  title = {CNM-Au8 in Amyotrophic Lateral Sclerosis: The HEALEY ALS Platform Trial.},
  author = {Writing Committee for the HEALEY ALS Platform Trial and Berry JD and Maragakis NJ and Macklin EA and Chibnik LB and Quintana M and Saville BR and Detry MA and Vestrucci M and Marion J and McGlothlin A and Stommel EW and Chase M and Pothier L and Harkey BA and Yu H and Sherman A and Shefner J and Hall M and Kittle G and Babu S and Andrews J and D'Agostino D and Tustison E and Scirocco E and Giacomelli E and Alameda G and Locatelli E and Ho D and Quick A and Ajroud-Driss S and Katz J and Heitzman D and Appel SH and Shroff S and Felice KJ and Simmons Z and Miller T and Olney N and Weiss MD and Goutman SA and Fernandes JA Jr and Jawdat O and Owegi MA and Foster L and Vu T and Ilieva H and Newman DS and Arcila-Londono X and Jackson C and Ladha S and Heiman-Patterson T and Caress J and Swenson A and Peltier A and Lewis R and Fee D and Elliott M and Bedlack R and Kasarskis EJ and Elman L and Rosenfeld J and Walk D and McIlduff CE and Twydell P and Young E and Johnson K and Rezania K and Goyal NA and Cohen JA and Benatar M and Jones V and Glass J and Shah J and Beydoun SR and Wymer JP and Zilliox L and Nayar S and Pattee GL and Martinez-Thompson J and Rynders A and Evan J and Evan J and Hartford A and Sepassi M and Ho KS and Glanzman R and Greenberg B and Hotchkin MT and Paganoni S and Cudkowicz ME and HEALEY ALS Platform Trial Study Group},
  year = {2025},
  journal = {JAMA},
  doi = {10.1001/jama.2024.27643},
  url = {https://doi.org/10.1001/jama.2024.27643}
}

RIS

TY  - JOUR
TI  - CNM-Au8 in Amyotrophic Lateral Sclerosis: The HEALEY ALS Platform Trial.
AU  - Writing Committee for the HEALEY ALS Platform Trial
AU  - Berry JD
AU  - Maragakis NJ
AU  - Macklin EA
AU  - Chibnik LB
AU  - Quintana M
AU  - Saville BR
AU  - Detry MA
AU  - Vestrucci M
AU  - Marion J
AU  - McGlothlin A
AU  - Stommel EW
AU  - Chase M
AU  - Pothier L
AU  - Harkey BA
AU  - Yu H
AU  - Sherman A
AU  - Shefner J
AU  - Hall M
AU  - Kittle G
AU  - Babu S
AU  - Andrews J
AU  - D'Agostino D
AU  - Tustison E
AU  - Scirocco E
AU  - Giacomelli E
AU  - Alameda G
AU  - Locatelli E
AU  - Ho D
AU  - Quick A
AU  - Ajroud-Driss S
AU  - Katz J
AU  - Heitzman D
AU  - Appel SH
AU  - Shroff S
AU  - Felice KJ
AU  - Simmons Z
AU  - Miller T
AU  - Olney N
AU  - Weiss MD
AU  - Goutman SA
AU  - Fernandes JA Jr
AU  - Jawdat O
AU  - Owegi MA
AU  - Foster L
AU  - Vu T
AU  - Ilieva H
AU  - Newman DS
AU  - Arcila-Londono X
AU  - Jackson C
AU  - Ladha S
AU  - Heiman-Patterson T
AU  - Caress J
AU  - Swenson A
AU  - Peltier A
AU  - Lewis R
AU  - Fee D
AU  - Elliott M
AU  - Bedlack R
AU  - Kasarskis EJ
AU  - Elman L
AU  - Rosenfeld J
AU  - Walk D
AU  - McIlduff CE
AU  - Twydell P
AU  - Young E
AU  - Johnson K
AU  - Rezania K
AU  - Goyal NA
AU  - Cohen JA
AU  - Benatar M
AU  - Jones V
AU  - Glass J
AU  - Shah J
AU  - Beydoun SR
AU  - Wymer JP
AU  - Zilliox L
AU  - Nayar S
AU  - Pattee GL
AU  - Martinez-Thompson J
AU  - Rynders A
AU  - Evan J
AU  - Evan J
AU  - Hartford A
AU  - Sepassi M
AU  - Ho KS
AU  - Glanzman R
AU  - Greenberg B
AU  - Hotchkin MT
AU  - Paganoni S
AU  - Cudkowicz ME
AU  - HEALEY ALS Platform Trial Study Group
PY  - 2025
JO  - JAMA
DO  - 10.1001/jama.2024.27643
UR  - https://doi.org/10.1001/jama.2024.27643
ER  -

APA

Trial, W. C. F. T. H. A. P., JD, B., NJ, M., EA, M., LB, C., M, Q., BR, S., MA, D., M, V., J, M., A, M., EW, S., M, C., L, P., BA, H., H, Y., A, S., J, S., M, H., G, K., S, B., J, A., D, D., E, T., E, S., E, G., G, A., E, L., D, H., A, Q., S, A., J, K., D, H., SH, A., S, S., KJ, F., Z, S., T, M., N, O., MD, W., SA, G., Jr, F. J., O, J., MA, O., L, F., T, V., H, I., DS, N., X, A., C, J., S, L., T, H., J, C., A, S., A, P., R, L., D, F., M, E., R, B., EJ, K., L, E., J, R., D, W., CE, M., P, T., E, Y., K, J., K, R., NA, G., JA, C., M, B., V, J., J, G., J, S., SR, B., JP, W., L, Z., S, N., GL, P., J, M., A, R., J, E., J, E., A, H., M, S., KS, H., R, G., B, G., MT, H., S, P., ME, C., & Group, H. A. P. T. S. (2025). CNM-Au8 in Amyotrophic Lateral Sclerosis: The HEALEY ALS Platform Trial.. JAMA. https://doi.org/10.1001/jama.2024.27643

Source records